Predictive BioSciences Lands $21,750,000 Series B Financing

  • Feed Type
  • Date
    10/16/2008
  • Company Name
    Predictive BioSciences
  • Mailing Address
    128 Spring Street, 400 Level, B Annex Lexington, MA 02421
  • Company Description
    Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors, experienced entrepreneurs, and internationally-renowned scientists in the areas of tumor growth, tumor angiogenesis, and cancer markers. Predictive Biosciences possesses an extensive IP portfolio – including 18 issued US patents – and deep in-house expertise in proteomics, diagnostics, oncology, and tumor biomarkers.
  • Website
    http://www.predictivebiosci.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,750,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Predictive intends to use the proceeds from the Series B financing to complete current clinical validation studies and initiate multi-center clinical trials.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Highland Capital Partners

By posting a comment, you agree to our terms and conditions.